BeyondSpring Inc. (BYSI) vs IGC Pharma, Inc. (IGC)

BeyondSpring Inc. and IGC Pharma, Inc. are both Biotechnology companies. BeyondSpring Inc. and IGC Pharma, Inc. are of similar size ($29.8M and $29.1M). BeyondSpring Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs −91.5%). Across the 15 metrics below, BeyondSpring Inc. leads on 12 and IGC Pharma, Inc. on 3.

Valuation

Metric BYSI IGC Biotechnology median
P/E n/m n/m 7.88
P/S 23.74 25.52 11.47
P/B n/m 4.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 21.16 26.18 10.73
Earnings yield (33.71%) (32.14%) (28.84%)
Free cash flow yield (52.37%) (20.24%) (23.03%)

Profitability

Metric BYSI IGC Biotechnology median
Gross margin 100.00% 32.33% 65.16%
Operating margin 0.00% (912.44%) 0.00%
Net margin 0.00% (795.46%) 0.00%
Free cash flow margin 0.00% (516.53%) 0.00%
Return on equity 24.96% (143.46%) (57.72%)
Return on assets (29.29%) (100.44%) (49.22%)
Return on invested capital 0.00% (91.53%) 0.00%

Growth

Metric BYSI IGC Biotechnology median
Revenue growth (TTM) — (13.38%) 5.64%
EPS growth (last fiscal year) 96.30% 57.85% —
Revenue growth, 5-year CAGR — (20.77%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BYSI IGC Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 0.70 0.39 4.73
Net debt to EBITDA 1.42 0.04 0.96

Dividend

Metric BYSI IGC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BYSI IGC Biotechnology median
Market cap 29.81m 29.11m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack